{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:14:29Z","timestamp":1760188469815},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1987,1,1]],"date-time":"1987-01-01T00:00:00Z","timestamp":536457600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"published-print":{"date-parts":[[1987]]},"DOI":"10.1007\/bf00931312","type":"journal-article","created":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T16:33:25Z","timestamp":1104597205000},"page":"157-164","source":"Crossref","is-referenced-by-count":22,"title":["CA 125 in the serum and tissue of patients with gynecological disease"],"prefix":"10.1007","volume":"241","author":[{"given":"L. C.","family":"Fuith","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Daxenbichler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Dapunt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1172\/JCI110380","volume":"58","author":"RC Bast","year":"1981","unstructured":"Bast RC, Feeney M, Lazarus H, Nadler LM, Colvin RB, Knapp RC (1981) Reactivity of a monoclonal antibody with human ovarian carcinoma. J Clin Invest 58:1331?1337","journal-title":"J Clin Invest"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJM198310133091503","volume":"309","author":"RC Bast","year":"1983","unstructured":"Bast RC, Klug TL, St John E, Jenison E, Niloff JM, Lazarus H, Berkowitz RS, Leavitt T, Griffiths T, Parker L, Lurawski VR, Knapp RC (1983) A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer. N Engl J Med 309:883?887","journal-title":"N Engl J Med"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/0002-9378(84)90035-8","volume":"149","author":"RC Bast","year":"1984","unstructured":"Bast RC, Klug TL, Schatzl E, Lavin P, Niloff JM, Greber TF, Zurawski VR, Knapp RC (1984) Monitoring human ovarian carcinoma with a combination of CA 125, CA 19-9 and carcinoembryonic antigen. Am J Obstet Gynecol 149:553?559","journal-title":"Am J Obstet Gynecol"},{"key":"CR4","first-page":"163","volume":"6","author":"Ch Bieglmayer","year":"1985","unstructured":"Bieglmayer Ch, Schieder K, Czaicsich P, Breitenecker G, Nowotny Ch (1985) Ovarial-Tumormarker CA 125: Ein onkofetales Protein. Tumordiagnostik Therapie 6:163?165","journal-title":"Tumordiagnostik Therapie"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0090-8258(85)90225-2","volume":"21","author":"PA Brioschi","year":"1985","unstructured":"Brioschi PA, Bischof P, Rapin C, de Roten M, Trion O, Krauer F (1985) Longitudinal study of CEA and CA 125 in ovarian cancer. Gynecol Oncol 21:1?6","journal-title":"Gynecol Oncol"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1055\/s-2008-1036234","volume":"45","author":"G Crombach","year":"1985","unstructured":"Crombach G, Zippel HH, W\ufffdrz H (1985) Erfahrungen mit CA 125, einem Tumormarker f\ufffdr maligne epitheliale Ovarialtumoren. Geburtshilfe Frauenheilk 45:205?212","journal-title":"Geburtshilfe Frauenheilk"},{"issue":"Suppl 2","key":"CR7","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1159\/000270012","volume":"25","author":"LC Fuith","year":"1985","unstructured":"Fuith LC, Hetzel H, Dapunt O (1985) Chemotherapie von Ovarialkarzinomen mit Cisplatinum und Adriamycin. Gynakol Rundsch [Suppl 2] 25:35?37","journal-title":"Gynakol Rundsch"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1093\/ajcp\/79.1.98","volume":"79","author":"SE Kabawat","year":"1983","unstructured":"Kabawat SE, Bast RC, Welch WR, Knapp RC, Colvin RB (1983) Immunopathologic characterization of a monoclonal antibody that recongnizes common surface antigens of human ovarian tumors of serous, endometrioid and clear cell types. Am J Clin Pathol 79:98?104","journal-title":"Am J Clin Pathol"},{"key":"CR9","first-page":"4217","volume":"48","author":"SE Kabawat","year":"1983","unstructured":"Kabawat SE, Bast RC, Bhan AK, Welch WR, Knapp RC, Colvin RB (1983) Tissue distribution of a coelomic epithelium-related antigen recognized by the monoclonal antibody OC 125. Lab Invest 48:4217","journal-title":"Lab Invest"},{"key":"CR10","first-page":"21","volume-title":"Annual report on the results of treatment in gynecological cancer, vol 17:21?25","author":"HL Kottmeier","year":"1979","unstructured":"Kottmeier HL (1979) Annual report on the results of treatment in gynecological cancer, vol 17:21?25. Radiumhemmet. Stockholm, pp 21?25"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/S0002-9378(84)90444-7","volume":"148","author":"JM Niloff","year":"1984","unstructured":"Niloff JM, Klug TL, Sch\ufffdtzl E, Zurawski VR, Knapp RC, Bast RC (1984) Evaluation of serum CA 125 in carcinomas of the fallopian tube, endometrium and endocervix. Am J Obstet Gynecol 148:1057?1058","journal-title":"Am J Obstet Gynecol"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/0002-9378(85)90678-7","volume":"7","author":"JM Niloff","year":"1985","unstructured":"Niloff JM, Bast RC, Sch\ufffdtzl EM, Knapp RC (1985) Predictive value of CA 125 antigen levels in second-look procedures for ovarian cancer. Am J Obstet Gynecol 7:981?984","journal-title":"Am J Obstet Gynecol"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1159\/000298927","volume":"21","author":"F Pansini","year":"1986","unstructured":"Pansini F, Bellinazzi A, Rainaldi V, Santoiemma M, Lenzl B, Jacobs M, Mollica G, Bagni B (1986) Serum CA in ovarian pathology and its variation in ovarian carcinoma after integrated therapy. Gynecol Obstet Invest 21:47?51","journal-title":"Gynecol Obstet Invest"},{"issue":"2","key":"CR14","first-page":"145","volume":"71","author":"A Ruibal","year":"1984","unstructured":"Ruibal A, Encabo G, Martinez-Miralles E, Murcia C, Capdevilla JA, Salgado A, Marinez-Vasquez JM (1984) CA 125 seric levels in non malignant pathologies. Bull Cancer 71, 2:145?148","journal-title":"Bull Cancer"},{"key":"CR15","first-page":"1068","volume-title":"Cancer medicine","author":"TA Waldmann","year":"1982","unstructured":"Waldmann TA, Heberman RB (1982) Tumor markers in diagnosis and in monitoring therapy. In: Holland JF, Frei E (eds) Cancer medicine, 2d edn. Lee & Febinger, Philadelphia, pp 1068?1089","edition":"2d edn."}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00931312.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00931312\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00931312","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,29]],"date-time":"2019-04-29T17:44:44Z","timestamp":1556559884000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00931312"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1987]]},"references-count":15,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1987]]}},"alternative-id":["BF00931312"],"URL":"https:\/\/doi.org\/10.1007\/bf00931312","relation":{},"ISSN":["0932-0067","1432-0711"],"issn-type":[{"value":"0932-0067","type":"print"},{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[1987]]}}}